Short answer · Medically reviewed summary · Last updated: 2026-04-07
Niemann-Pick disease is a group of inherited metabolic disorders historically categorized together, now more precisely classified into distinct types (A, B, and C) based on their specific genetic and biochemical causes. Historical and Alternative Nomenclature In older medical literature, you may encounter terms such as sphingomyelin lipidosis or sphingomyelinase deficiency, which refer specifically to types A and B. Because Niemann-Pick disease was originally described as a single entity, the name has persisted as an umbrella term.
Niemann-Pick disease is a group of inherited metabolic disorders historically categorized together, now more precisely classified into distinct types (A, B, and C) based on their specific genetic and biochemical causes.
In older medical literature, you may encounter terms such as sphingomyelin lipidosis or sphingomyelinase deficiency, which refer specifically to types A and B. Because Niemann-Pick disease was originally described as a single entity, the name has persisted as an umbrella term. However, clinicians now differentiate between types A/B (acid sphingomyelinase deficiency) and type C (a distinct cholesterol trafficking disorder). You might also see the abbreviation NPD used in clinical notes, though this is becoming less common as doctors move toward specific subtype designations.
The naming convention for Niemann-Pick disease has evolved to reflect our deepening understanding of the underlying genetics. In official classification systems like the ICD-10 and ICD-11, the condition is coded under lysosomal storage diseases. Orphanet and OMIM (Online Mendelian Inheritance in Man) now prioritize the specific enzyme or protein deficiency, such as Acid Sphingomyelinase Deficiency (ASMD) for types A and B, and Niemann-Pick disease type C (NPC) for the distinct neurovisceral form. This reclassification is critical because the pathophysiology and treatment approaches for type C differ significantly from those for types A and B.
The variety of names for Niemann-Pick disease exists because the condition was first identified through clinical observation before the specific genetic mutations were known. As medical science moved from observing "foam cells" under a microscope to identifying specific gene mutations (like SMPD1 for types A/B and NPC1 or NPC2 for type C), the terminology shifted. Today, medical professionals prefer using the specific subtype—such as Niemann-Pick disease type C—to ensure the most accurate diagnostic and therapeutic communication.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.